Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 12, 2019 - Issue
Submit an article Journal homepage
108
Views
4
CrossRef citations to date
0
Altmetric
Original Research

CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese

Elaine Chow1 Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong;2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong KongCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4147-3387
ORCID Icon,
Emily WM Poon2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
,
Benny SP Fok1 Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong
,
Juliana CN Chan2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong KongORCID Iconhttps://orcid.org/0000-0003-1325-1194
ORCID Icon &
Brian Tomlinson1 Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong;2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong;3 Faculty of Medicine, Macau University of Science & Technology, Taipa, MacauORCID Iconhttps://orcid.org/0000-0001-6717-5444
ORCID Icon
Pages 397-401 | Published online: 03 Jan 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Brian Tomlinson & Yan-Hong Li. (2023) What is the impact of type 2 diabetes mellitus on CYP450 metabolic activities?. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-4.
Read now
Brian Tomlinson, Yan-Hong Li & Paul Chan. (2022) Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 23:17, pages 1869-1877.
Read now
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok, Paul Chan & Christopher Wai Kei Lam. (2022) The role of sulfonylureas in the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 23:3, pages 387-403.
Read now

Articles from other publishers (1)

Pureum Kang, Chang-Keun Cho, Choon-Gon Jang, Seok-Yong Lee, Yun Jeong Lee, Chang-Ik Choi & Jung-Woo Bae. (2023) Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects. Archives of Pharmacal Research 46:5, pages 438-447.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.